Quinine Extraction

Part of Pharmacy and Apothecary

Extracting the antimalarial compound quinine from cinchona bark for treating and preventing malaria in regions where the disease is present.

Why This Matters

Malaria kills more people than almost any other infectious disease on Earth. Before synthetic chloroquine and artemisinin derivatives, quinine from cinchona bark was the only effective treatment. It remained the primary antimalarial from the 1600s — when Jesuit missionaries brought cinchona bark from Peru to Europe — until the 1930s. In a post-collapse world, if you live in a malaria zone, cinchona bark may be the difference between life and death for your community.

The quinine alkaloid works by interfering with the malaria parasite’s ability to process hemoglobin in the patient’s red blood cells. A therapeutic blood level of quinine prevents parasites from reproducing; higher levels kill them. The challenge is that therapeutic doses and toxic doses are not enormously different — quinine causes cinchonism (ringing ears, vision disturbance, headache) at therapeutic levels, and cardiac arrhythmias, blindness, or death at overdose. Extraction and dosing must be done with care.

Even in regions where malaria is not present, this knowledge has value — cinchona bark preparations were used as tonics (the origin of tonic water), for leg cramps, and for certain fever presentations. But the primary value is antimalarial, and this document is written with that application in mind.

Cinchona Bark: Sources and Identification

Cinchona (Cinchona officinalis, C. pubescens, and related species) is a tree native to the Andes of South America. It has been widely cultivated in tropical regions of Asia (particularly Java, now Indonesia), East Africa (particularly Congo and Kenya), and Central America for pharmaceutical production. Any of these cultivated populations may be accessible depending on your location.

Identification:

• Medium to large tree, 5-20 meters
• Leaves: oval to elongated, glossy dark green, opposite on stem
• Flowers: small, pink-red, tubular, in terminal clusters; intensely fragrant
• Bark: brownish-grey on the outside, pinkish-red on the inner surface
• Characteristic intensely bitter taste of the bark (any bark that is extremely bitter is a candidate for alkaloid content)

Quinine content by species and part:

• C. ledgeriana bark: highest quinine content (5-8%)
• C. officinalis bark: 2-4% quinine
• Root bark: highest content per tree; trunk bark next; branch bark lowest
• Dry season bark: slightly higher alkaloid content than wet season

Substitute bark sources: Several related plants have lower quinine content. In some regions, other Cinchona species or Remijia species have been used. If cinchona is unavailable, note that there is NO effective substitute plant for malaria treatment — artemisinin from sweet wormwood (Artemisia annua) is the only other well-established plant-based antimalarial, requiring different extraction.

Extraction Method

Quinine alkaloids are poorly soluble in water alone but dissolve readily in acidified water and in alcohol. The standard extraction uses acid for initial dissolution, followed by a base to precipitate the alkaloid.

Simplified extraction for practical use (without laboratory reagents):

Acid-water extraction:

1. Grind dried cinchona bark to coarse powder — a mortar and pestle or stone grinding works
2. Combine 50 grams powdered bark with 500 mL water and 30 mL vinegar (5% acetic acid) or lemon juice
3. Bring to a simmer and maintain for 30 minutes
4. Strain through fine cloth, pressing firmly
5. Repeat extraction on remaining bark with fresh acidified water
6. Combine both extracts

This acid extract contains quinine salts in solution. It tastes extremely bitter. It can be administered directly as a medicinal preparation at this stage.

Dose of crude acid extract:

• For malaria treatment: approximately 100-150 mL of the strained extract (from 50g bark/500 mL water ratio) three times daily for 7 days
• The very bitter taste is the dose indicator — the preparation should be extremely bitter
• If it is only mildly bitter, the extraction was insufficient or the bark quality was low; do not assume a mild preparation is adequate

Concentration and stabilization:

• Reduce the acid extract by simmering (uncovered, gentle heat) to half or one-quarter volume — concentrating alkaloids and allowing smaller dose volumes
• A concentrated reduction of 150 mL starting material to 50 mL can be given as a 50 mL dose three times daily
• Store in sealed containers in cool, dark location; use within 5-7 days

Alcohol tincture (longer shelf life):

1. Prepare acid-water extract as above
2. Add an equal volume of high-proof alcohol (60%+ ideally)
3. Stir, allow to stand 24 hours
4. The quinine alkaloids transfer into the alcohol-acid mixture
5. Filter and store — shelf life months to years
6. Dose: 15-30 mL of tincture three times daily

Dosing and Treatment Protocol

For acute malaria treatment:

• Adult dose: 7-10 mg quinine base per kg body weight, three times daily, for 7 days
• For a 70 kg adult, this is approximately 490-700 mg quinine per dose, 3x daily
• Without laboratory testing, you cannot know exact quinine content of your bark or preparation. Use the crude extraction at the doses described above as a practical approximation.

Monitoring:

• Therapeutic effect: fever should begin breaking within 24-48 hours
• Cinchonism (expected at therapeutic doses): ringing in the ears (tinnitus), headache, nausea, visual disturbance — these are signs you are at or near therapeutic levels
• Overdose signs: severe vomiting, delirium, vision loss, cardiac irregularity — reduce dose immediately

For malaria prevention (where high endemic transmission occurs):

• Smaller daily dose: approximately one-third of therapeutic dose, taken daily
• Prophylaxis is less reliable with crude preparations than pharmaceutical quinine; maximize other prevention (bed nets, mosquito control)

Artemisia annua as Alternative

Where cinchona is unavailable, sweet wormwood (Artemisia annua) contains artemisinin, now the foundation of modern first-line malaria treatment. However, artemisinin extraction is more complex and temperature-sensitive than quinine extraction.

Artemisia annua simple preparation:

• Cold-infuse (never heat — artemisinin is heat-sensitive) dried plant material
• 5 grams dried herb per 500 mL cold water, steep 8 hours
• Adult dose: 200-300 mL of this cold infusion twice daily for 7 days
• Limited evidence for dosing; quinine extraction from cinchona is preferred if bark is available

Toxicity Warnings

Do not use quinine preparations in:

• Pregnancy (causes uterine contractions — can induce miscarriage or premature labor)
• Patients with known cardiac arrhythmias
• Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency (common in malaria-endemic populations — can cause severe hemolysis; if you cannot test, proceed with caution and monitor for dark urine)
• Patients with severe kidney failure

Quinine and glucose: Quinine stimulates insulin release. Malaria itself causes hypoglycemia (low blood sugar). Patients receiving quinine for malaria should receive adequate food/sugar to prevent dangerous hypoglycemia. This is an important clinical concern, especially in children.

Document every preparation made, every patient treated, and every outcome in your dispensing records. In a malaria-endemic community, this data is essential for optimizing the extraction and dosing protocol for your specific bark source.